E1505 – A Phase III Randomized Trial of Adjuvant Chemotherapy with or without Bevacizumab for Patients with Completely Resected Stage IB-IIIA Non-Small Cell Lung Cancer (NSCLC)

Physician and Research Staff Educational Materials:

These materials are intended for promotional use among health care professionals and are NOT intended for use as patient educational materials.

  • Trial Overview: detailed overview of the protocol, disease state, and rationale for evaluating chemotherapy with or without bevacizumab in head and neck cancer.
  • Pocket Reference Card: trial schema, study objectives, and eligibility requirements on a pocket-sized card for easy reference when consulting with patients in the office or on rounds.
  • Study Summary for Physicians: schema, study objectives, eligibility criteria, and other key information about the study.
  • Physician Fact Sheet: schema, study objectives, eligibility criteria, and other key information about the study.

Patient Educational Materials:

  • Study Summary for Patients: study objectives, eligibility criteria, and a simplified schema in lay language to provide a more visual description of the trial to patients.
  • Patient FAQs: frequently asked questions from patients about treatment, eligibility criteria, and potential enrollment issues, with answers in lay language.

Additional Information at ClinicalTrials.gov:

NCT00324805